Zobrazeno 1 - 10
of 86
pro vyhledávání: '"Yan Luo"'
Autor:
Yandi Sun, Xueyun Zhang, Lihong Zhang, Mashaal Ahmad, Xueyao Jia, Ze Yang, Qian Jin, Zara Ahmad Khan, Yindan Lin, Jingjia Li, Yan Luo
Publikováno v:
Genes & Diseases. 9:1345-1356
Inflammatory, proliferative and remodeling phases constitute a cutaneous wound healing program. Therapeutic applications and medication are available; however, they commonly are comprised of fortified preservatives that might prolong the healing proc
Autor:
Jingjing Qi, Qi Zhao, Huai-Qiang Ju, Lei Miao, Qi Nian Wu, Jia Liu, Xiao Li Wei, Jun Chen, Rui-Hua Xu, Da Liang Wei, Zhao Lei Zeng, Hui Yan Luo
Publikováno v:
Theranostics
Rationale: STING is a critical player in the innate and adaptive immune system, sensing cytosolic DNA to activate the expression of interferon genes and regulate T lymphocytes, which drives immunogenic responses to cancer cells. Tumor-associated macr
Autor:
Jonathan L. Kaufman, Nizar J. Bahlis, Jeremy A. Ross, Simon D. J. Gibbs, Yan Luo, Torben Plesner, Christine Mantis, Eva Medvedova, Philippe Moreau, Deeksha Vishwamitra, Shir-Jing Ho, Orlando F. Bueno, Annette Juul Vangsted, Hang Quach, Rachid Baz, Simon J. Harrison
Publikováno v:
Bahlis, N J, Kaufman, J L, Baz, R, Quach, H, Ho, S-J, Vangsted, A J, Plesner, T, Moreau, P, Gibbs, S D, Medvedova, E, Bueno, O F, Luo, Y, Mantis, C, Vishwamitra, D, Ross, J A & Harrison, S J 2021, ' Rapid and Sustained Reduction of Immunosuppressive T-Cells and Focusing of the T-Cell Repertoire in t(11;14) Relapsed/Refractory Multiple Myeloma Patients Treated with Venetoclax in Combination with Daratumumab and Dexamethasone ', Blood, vol. 138, no. Suppl. 1, 1633 . https://doi.org/10.1182/blood-2021-146012
Background: Venetoclax (Ven) is a highly selective, potent, oral BCL-2 inhibitor that is currently being evaluated as a targeted therapy for the treatment of t(11;14) relapsed/refractory multiple myeloma (RRMM). The combination of Ven with daratumuma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f7b3429a1aff23dbdd303436f7b5654
https://portal.findresearcher.sdu.dk/da/publications/2aab7aad-040e-4740-a8b6-1754586ba081
https://portal.findresearcher.sdu.dk/da/publications/2aab7aad-040e-4740-a8b6-1754586ba081
Autor:
Jinbao Li, Zhuochen Lyu, Shiyuan Luo, Feng Chen, Yan Luo, Qing Tu, Yuan Yuan, Liangfang Yao, Yinjiao Li
Background: Sepsis-associated encephalopathy (SAE) is one of the severe central nervous system complications. Oxidative stress and synaptic dysfunction were involved in cognitive impairment induced by SAE. The mitochondrial nicotinamide adenine dinuc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ccc999fe8d8426a852eb097d4746cf2c
https://doi.org/10.21203/rs.3.rs-895666/v1
https://doi.org/10.21203/rs.3.rs-895666/v1
Autor:
Scott T. Tagawa, Karl D. Lewis, Christine H. Chung, Himisha Beltran, Ricardo Valenzuela, Jiaxin Niu, Christine L. Hann, Andrew Eugene Hendifar, David S. Hong, Rahul Aggarwal, Aaron S. Mansfield, Michael Rossi, Anna F. Farago, Saiama N. Waqar, Carrianne Ludwig, Lowell B. Anthony, James M. Cleary, Matthew H. Taylor, Alan H. Bryce, Yan Luo
Publikováno v:
NPJ Precision Oncology
npj Precision Oncology, Vol 5, Iss 1, Pp 1-7 (2021)
npj Precision Oncology, Vol 5, Iss 1, Pp 1-7 (2021)
3552 Background: Delta-like 3 (DLL3) is highly and specifically expressed in solid tumors, such as neuroendocrine carcinomas (NECs), malignant melanoma (MM), and medullary thyroid carcinoma (MTC). Rovalpituzumab tesirine (Rova-T) is a DLL3-targeting
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology
Frontiers in Oncology
PurposeTo assess T2*-weighted imaging (T2*WI) and reduced field-of-view diffusion-weighted Imaging (rDWI) derived parameters and their relationships with histopathological factors in patients with rectal cancer.MethodsFifty-four patients with patholo
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology
Frontiers in Oncology
ObjectiveTo explore whether risk stratification based on ultrasound elastography of liver background assists contrast-enhanced ultrasound liver imaging reporting and data system (CEUS LI-RADS) in diagnosing HCC.Materials and MethodsIn total, 304 pati
Publikováno v:
The Journal of Gene Medicine
Background Ectopic thymic carcinoma (TC) is an extremely rare disease with a poor prognosis. The main treatment for early TC is surgery, although an effective treatment for advanced TC is lacking. Methods We present the case of a 61‐year‐old man
Autor:
Yan Lu, Yi Xiao, Ming-Zhu Yin, Xing-Chen Zhou, Li-Sha Wu, Wang-Qing Chen, Yan Luo, Ye-Hong Kuang, Wu Zhu
Publikováno v:
Frontiers in Medicine
Frontiers in Medicine, Vol 7 (2021)
Frontiers in Medicine, Vol 7 (2021)
Objective: To explore the possible mechanism of improving the imiquimod (IMQ)-induced psoriasis-like inflammation by using polyethylene glycol (PEG) ointment.Methods: We evaluated the appearance of psoriasis lesions by Psoriasis Area and Severity Ind
Publikováno v:
Cancer Biol Ther
Background The prognostic value of Chemokine (C-X-C motif) ligand 1 (CXCL1) in various types of cancer remains controversial. Here we aimed to evaluate the prognostic role of CXCL1 for cancer. Methods A comprehensively search of the PubMed, Embase, W